Pathway,Score
Signaling by VEGF,0.004272980642024182
Negative regulation of the PI3K/AKT network,0.02050701536559924
PI3K/AKT Signaling in Cancer,0.08905115107323862
G beta:gamma signalling through PI3Kgamma,0.026698672768237203
G-protein beta:gamma signalling,-0.020257441345905573
VEGFA-VEGFR2 Pathway,-0.006074899519408505
VEGFR2 mediated vascular permeability,0.003201818968748865
Constitutive Signaling by AKT1 E17K in Cancer,0.03928247922299948
Respiratory Syncytial Virus Infection Pathway,0.04122144014272044
RSV-host interactions,0.013931447085587228
RHO GTPases Activate WASPs and WAVEs,-0.027786013030582795
RAC2 GTPase cycle,0.027810145396232836
RAC3 GTPase cycle,-0.08785776459961438
Parasite infection,0.10072090184865756
Leishmania phagocytosis,-0.008609328890102602
FCGR3A-mediated phagocytosis,0.00021257150203253902
Signaling by NOTCH1,-0.005108201533828731
NOTCH1 Intracellular Domain Regulates Transcription,-0.011369740494108294
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.00824222126025168
Signaling by NOTCH1 in Cancer,0.009474521155495066
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.044392356038144426
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.029630960432676795
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.01345037398871609
Regulation of PTEN gene transcription,0.035861971678650434
Budding and maturation of HIV virion,0.0648611725887901
Uptake and actions of bacterial toxins,0.022031486458304148
Bacterial Infection Pathways,-0.08525084384573224
NRAGE signals death through JNK,-0.016501920131527698
p75 NTR receptor-mediated signalling,-0.012500151031989556
"Cell death signalling via NRAGE, NRIF and NADE",0.059847300808339485
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,-0.0061303117671796855
Neurodegenerative Diseases,0.02383452061002394
Diseases of programmed cell death,0.07114985357202366
Defective Intrinsic Pathway for Apoptosis,-0.0007245271595471873
Signaling by SCF-KIT,-0.0135112884302465
Regulation of KIT signaling,0.02076675609805388
Degradation of beta-catenin by the destruction complex,-0.009116510965432952
Beta-catenin phosphorylation cascade,0.01184570368953862
Disassembly of the destruction complex and recruitment of AXIN to the membrane,-0.015404759562781138
G alpha (12/13) signalling events,0.12772727711603415
Pre-NOTCH Transcription and Translation,-0.05083573617304713
Pre-NOTCH Expression and Processing,-0.05919998073532044
Signaling by NOTCH2,-0.060630207026932434
NOTCH2 intracellular domain regulates transcription,-0.029145537976031383
Signaling by NOTCH3,0.01708264648716287
NOTCH3 Intracellular Domain Regulates Transcription,-0.018394908900231252
Signaling by NOTCH4,-0.0014499810401062145
NOTCH4 Intracellular Domain Regulates Transcription,-0.00441604672976893
Signaling by MET,0.03968526438537465
RAS processing,0.02076119344763501
Potential therapeutics for SARS,-0.026423142093792415
Host Interactions of HIV factors,-0.0536752289314168
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.016246396450670157
The role of Nef in HIV-1 replication and disease pathogenesis,0.01150364251273988
NR1H2 and NR1H3-mediated signaling,0.003512875858851835
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.051993780857926414
Diseases of glycosylation,0.03421314993254856
Diseases associated with O-glycosylation of proteins,0.01396372768294919
Defective GALNT3 causes HFTC,-0.0167825113182114
Defective GALNT12 causes CRCS1,0.022082094872857727
Diseases of metabolism,0.01923767861551472
Diseases of DNA repair,0.08742850968510792
Diseases of DNA Double-Strand Break Repair,-0.014718741728456004
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.021012253866681273
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.0043434607555586785
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.009340840471618733
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,0.011720399659935163
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.007621238936373777
Impaired BRCA2 binding to RAD51,0.014755307842412212
Impaired BRCA2 binding to PALB2,0.03067170381316786
Effects of PIP2 hydrolysis,-0.05073395569242916
Integrin signaling,0.0015918430181336212
Retrograde neurotrophin signalling,0.0001085605996644794
Signaling by NTRK1 (TRKA),-0.08099467091693822
TNFR1-induced proapoptotic signaling,-0.004795035162371157
Regulation of TNFR1 signaling,-0.04838070617796744
TNFR1-induced NF-kappa-B signaling pathway,0.08294534589503938
TNF signaling,0.0029651911235635733
RHOA GTPase cycle,0.031309701566428
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.023674021681275897
HCMV Infection,-0.004918264201657677
HCMV Early Events,0.0006458781933104171
Regulation of RAS by GAPs,-0.056836326624651365
RHOF GTPase cycle,-0.022382481683646323
P2Y receptors,-0.013187578121190233
Nucleotide-like (purinergic) receptors,0.0028995902624804584
Signaling by PTK6,-0.04006234639264816
Signaling by Non-Receptor Tyrosine Kinases,0.016908465372976356
Signaling by Retinoic Acid,-0.05483688295118474
RA biosynthesis pathway,-0.061008151799768894
Signaling by ERBB2,-0.006828160405334767
Downregulation of ERBB2 signaling,0.031199170393451135
Activated NOTCH1 Transmits Signal to the Nucleus,0.011939452040325154
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.1182507533425285
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.0568059129186402
Opioid Signalling,-0.04828276698156248
DARPP-32 events,0.028694006764725728
Nuclear Events (kinase and transcription factor activation),-0.01342981894691231
Signaling by NTRK2 (TRKB),-0.027419954753028282
NGF-stimulated transcription,0.006097244446202161
Class B/2 (Secretin family receptors),0.07528030329305495
G alpha (s) signalling events,-0.08766499868101475
RHOB GTPase cycle,0.001576507344242845
RHOC GTPase cycle,-0.001370721195073412
Vpu mediated degradation of CD4,0.010974553422623847
Vif-mediated degradation of APOBEC3G,-0.030217385319023723
PCP/CE pathway,-0.08454641855608849
Asymmetric localization of PCP proteins,0.007479261590245945
Degradation of AXIN,0.033142654853077755
Degradation of DVL,-0.0015673925779330783
Hedgehog ligand biogenesis,-0.04519948648482086
Hh mutants are degraded by ERAD,-0.012612849041705298
Hh mutants abrogate ligand secretion,0.012659374388198363
Degradation of GLI1 by the proteasome,-0.005019460139150496
Degradation of GLI2 by the proteasome,-0.06943826970029046
GLI3 is processed to GLI3R by the proteasome,-0.0319019342045826
Hedgehog 'off' state,-0.007589687518623004
ABC transporter disorders,0.002282451972942927
Disorders of transmembrane transporters,0.0036307403610387765
Hedgehog 'on' state,0.10102648128496347
Defective CFTR causes cystic fibrosis,0.167428698506948
MAPK6/MAPK4 signaling,0.0827849103474032
Regulation of PTEN stability and activity,-0.008875124932463377
Negative regulation of NOTCH4 signaling,0.007171726450202947
Formation of HIV elongation complex in the absence of HIV Tat,-0.02546794903350743
Formation of the HIV-1 Early Elongation Complex,-0.023225086294053197
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.020340666565502655
HIV Transcription Initiation,0.012298495727540017
RNA Polymerase II HIV Promoter Escape,-0.011265740406730593
HIV Transcription Elongation,-0.06098759159713898
Transcription of the HIV genome,0.016271179582438032
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.025592877878302233
Tat-mediated elongation of the HIV-1 transcript,-0.034714438333259094
RHOBTB3 ATPase cycle,0.016809094987739394
Signaling by TGF-beta Receptor Complex,0.07521145310033897
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.02822142531257892
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.034979992049942815
Pausing and recovery of Tat-mediated HIV elongation,0.0017466034538748765
Tat-mediated HIV elongation arrest and recovery,-0.029062019455530087
HIV elongation arrest and recovery,0.01023714647536417
Pausing and recovery of HIV elongation,-0.011768899708078434
Estrogen-dependent gene expression,0.019335349650824257
RHOBTB2 GTPase cycle,0.06750342546094228
RHOBTB1 GTPase cycle,0.03679891732947147
RHOBTB GTPase Cycle,-0.02988004364046402
Signaling by EGFR,0.007535854970475834
EGFR downregulation,-0.0030385558199604325
Signaling by FGFR,0.16937837362249228
Negative regulation of FGFR1 signaling,0.0075173867960358675
Negative regulation of FGFR2 signaling,0.004957673291196557
Negative regulation of FGFR3 signaling,-0.008405660490214226
Negative regulation of FGFR4 signaling,0.05003658400661548
Signaling by FGFR1,0.03793216591575133
Signaling by FGFR2,0.04751650322344044
Signaling by FGFR3,-0.018719665781680845
Signaling by FGFR4,0.018344012992734204
Negative regulation of MET activity,-0.010975967489847386
InlB-mediated entry of Listeria monocytogenes into host cell,0.03611750801267982
Listeria monocytogenes entry into host cells,0.017244847944861055
RHOU GTPase cycle,0.004131136660202534
MAP2K and MAPK activation,0.04853471355065703
Signaling by moderate kinase activity BRAF mutants,0.028199618267721046
Signaling by high-kinase activity BRAF mutants,0.020245710714437967
Signaling by RAS mutants,0.007044704088478246
Signaling by BRAF and RAF1 fusions,-0.019523070089303582
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.015414927742969433
Oncogenic MAPK signaling,-0.004829986582032443
Signaling downstream of RAS mutants,0.0028232107558924494
Signaling by RAF1 mutants,0.02688262699606695
AKT phosphorylates targets in the cytosol,-0.01487484332524301
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.004101171806345714
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.018917501582254012
Diseases of mitotic cell cycle,-0.0044566943268905725
FLT3 signaling in disease,-0.01059617643282029
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.00353309954174938
Signaling by ALK in cancer,-0.024217519759142665
Signaling by FLT3 ITD and TKD mutants,-0.0055023105165646746
Signaling by ALK fusions and activated point mutants,-0.02168459498602504
RHO GTPases activate CIT,0.06459144176442902
Extra-nuclear estrogen signaling,0.010484449549594845
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,-0.0005579521317268487
Signaling by Activin,-0.000998287337462438
Downregulation of TGF-beta receptor signaling,-0.01946236696692876
TGF-beta receptor signaling activates SMADs,0.018103492833968407
G alpha (z) signalling events,-0.03899187587253379
Activation of RAC1,-0.002256483499128599
RHOQ GTPase cycle,-0.07500305371111265
RHOH GTPase cycle,-0.0430770076967243
RHOG GTPase cycle,-0.004206505795951405
RHOJ GTPase cycle,0.10110556764626781
RHOV GTPase cycle,-0.012328004411206865
Signaling by Insulin receptor,0.02534183937474165
Insulin receptor recycling,0.05398306023328834
MET activates PTK2 signaling,0.0012315925598526288
MET promotes cell motility,-0.08190330832749022
MTOR signalling,-0.009484659560912306
mTORC1-mediated signalling,0.00013106968976678697
Energy dependent regulation of mTOR by LKB1-AMPK,0.005937294112890593
Diseases of Immune System,0.01085353949036149
Diseases associated with the TLR signaling cascade,-0.008658939751362225
RHO GTPases activate IQGAPs,-0.007102516102793063
RHO GTPases Activate Formins,0.04777234058882266
RHO GTPases activate PKNs,-0.044371024937970995
RHO GTPases Activate ROCKs,-0.018549064898949256
RHO GTPases activate PAKs,-0.03528446528859391
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.007576501078466115
Pre-NOTCH Processing in Golgi,0.016456950274283913
Signaling by ERBB4,-0.01748131148802689
Nuclear signaling by ERBB4,0.004999939859779769
Signaling by Hippo,0.057831784363981835
RHOD GTPase cycle,-0.016598715970550317
SARS-CoV-1-host interactions,-0.12888331031747416
SARS-CoV-1 activates/modulates innate immune responses,-0.015925063217375614
RND3 GTPase cycle,0.040825697066427066
Nuclear events stimulated by ALK signaling in cancer,-0.020835165208445396
HCMV Late Events,-0.03347205230797046
Formation of the beta-catenin:TCF transactivating complex,0.07818188212322263
Peptide ligand-binding receptors,-0.007058128843030477
Chemokine receptors bind chemokines,0.004817701113538566
Translation of Structural Proteins,-0.006900852292622323
Maturation of spike protein,0.02369570704133514
Late SARS-CoV-2 Infection Events,-0.08477274363179237
Purinergic signaling in leishmaniasis infection,-0.005417609426955636
Cell recruitment (pro-inflammatory response),0.03734160004689761
CaMK IV-mediated phosphorylation of CREB,0.011997998370599347
Calmodulin induced events,-0.011630323966916642
Ca-dependent events,0.012381406302691805
CaM pathway,-0.01341751002495943
G-protein mediated events,0.024740910716627828
PLC beta mediated events,-0.03323603056792005
DAG and IP3 signaling,0.007863325939569236
G-protein activation,-0.0009906777254331176
Ca2+ pathway,-0.06243923826448533
G beta:gamma signalling through PLC beta,-0.0004361621622702837
Glucagon-type ligand receptors,0.05680270788076956
G beta:gamma signalling through BTK,-0.04437071262742861
G beta:gamma signalling through CDC42,-0.013206054188096387
GPER1 signaling,0.003228856732904747
ADORA2B mediated anti-inflammatory cytokines production,0.003745326314728177
Anti-inflammatory response favouring Leishmania parasite infection,-0.0108265002166952
Leishmania parasite growth and survival,-0.015230175496683944
PKA-mediated phosphorylation of CREB,-0.04358659988353151
PKA activation,0.016182131258792927
Adenylate cyclase activating pathway,0.002604211728584774
Adenylate cyclase inhibitory pathway,-0.010521260900503728
FCGR3A-mediated IL10 synthesis,-0.02970162868916058
Signaling by ERBB2 in Cancer,0.005713654907029537
Constitutive Signaling by Aberrant PI3K in Cancer,0.015624133055577298
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.09337352721162874
Signaling by ERBB2 KD Mutants,-0.0040310515554412615
Signaling by ERBB2 TMD/JMD mutants,0.0022713808386734366
RND2 GTPase cycle,0.011548387961475882
Signaling by TGFBR3,0.016051394795167012
Rev-mediated nuclear export of HIV RNA,-0.006930127093139359
Transport of Ribonucleoproteins into the Host Nucleus,0.0002019161321616023
Export of Viral Ribonucleoproteins from Nucleus,-0.008691711681244106
NS1 Mediated Effects on Host Pathways,-0.007599138329323874
Viral Messenger RNA Synthesis,0.02564826419722388
NEP/NS2 Interacts with the Cellular Export Machinery,-0.010416818566430711
Interactions of Vpr with host cellular proteins,0.08358775937873757
Interactions of Rev with host cellular proteins,0.0025816000856549526
Nuclear import of Rev protein,-0.03877043303664371
Vpr-mediated nuclear import of PICs,0.002206937080170083
SLC transporter disorders,-0.03399226048828344
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.008798894606798115
VEGFR2 mediated cell proliferation,0.003347139518161926
Eicosanoid ligand-binding receptors,-0.031644560866422214
RHO GTPases Activate NADPH Oxidases,-0.000656599767030436
Downstream signaling of activated FGFR1,-0.012376934035806244
FRS-mediated FGFR1 signaling,-0.006298005596524299
Downstream signaling of activated FGFR2,0.01692387677892437
FRS-mediated FGFR2 signaling,0.0066021554708110995
FRS-mediated FGFR3 signaling,0.0022544495594262128
Downstream signaling of activated FGFR3,-0.02723144893607769
FRS-mediated FGFR4 signaling,-0.00691924749381305
Downstream signaling of activated FGFR4,-0.00852228529244206
RND1 GTPase cycle,-0.03347663949462166
Signaling by FGFR in disease,0.007200343156644817
Prolonged ERK activation events,-0.0024116620232141938
Frs2-mediated activation,-0.004382241251742831
Signalling to ERKs,-0.10391617482738807
Signaling by ALK,-0.01862664375110096
Signaling by FGFR2 in disease,-0.020024977808281975
Signaling by FGFR1 in disease,-0.04112705753971368
Signaling by FGFR3 in disease,0.010909402822992173
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.0014894514142664932
Activation of SMO,0.006173229730028373
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.020744960841561258
Signaling by EGFR in Cancer,0.009843958491772335
Constitutive Signaling by EGFRvIII,0.0009307591501909364
Signaling by EGFRvIII in Cancer,0.020323606946709653
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.024238620416392583
Signaling by ERBB2 ECD mutants,0.015627229264912713
Infection with Mycobacterium tuberculosis,-0.0005661771327333097
Response of Mtb to phagocytosis,-0.013081851635340168
Signaling by BMP,-0.008303428088210196
Early Phase of HIV Life Cycle,-0.007895415553361013
SARS-CoV-2 modulates host translation machinery,-0.02167101329419007
RAF-independent MAPK1/3 activation,-0.006775786497538445
Negative regulation of MAPK pathway,0.005456158918858362
Viral mRNA Translation,-0.019328597413390484
Amine ligand-binding receptors,-0.04460697524401747
Neurotoxicity of clostridium toxins,0.02848736572661996
SARS-CoV-2 modulates autophagy,-0.011185328503708746
PI3K Cascade,-0.02784835923045596
IRS-mediated signalling,-0.020625420164491915
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.040315099927572144
IGF1R signaling cascade,-0.041872065056364545
IRS-related events triggered by IGF1R,0.0015186832821325745
Insulin receptor signalling cascade,-0.014342567963156465
WNT5A-dependent internalization of FZD4,0.012061962044456661
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.04355310402972233
Induction of Cell-Cell Fusion,-0.03515597508554956
Signaling by PDGF,0.015658475891289426
Translation of Replicase and Assembly of the Replication Transcription Complex,0.03698767288262428
Early SARS-CoV-2 Infection Events,0.037485403803657454
Assembly Of The HIV Virion,-0.04932839371469959
Evasion by RSV of host interferon responses,0.009600528923061515
Downstream signal transduction,0.01609411205960231
p130Cas linkage to MAPK signaling for integrins,-0.02993019654651294
Signaling by Erythropoietin,0.04561349322564156
SARS-CoV-1 modulates host translation machinery,0.012492111704204698
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-0.011000406080057985
Maturation of nucleoprotein,0.014552643337830648
Signalling to RAS,0.01592108003315896
FGFR2 ligand binding and activation,-0.00979506971972725
Signaling by WNT in cancer,-0.022645325942005638
Signaling by AXIN mutants,0.0438589071937708
Signaling by CTNNB1 phospho-site mutants,-0.004641214116926722
Signaling by APC mutants,0.0033357970748576046
Signaling by AMER1 mutants,0.006406286902863035
Signaling by GSK3beta mutants,-0.015040835676616463
CTNNB1 S33 mutants aren't phosphorylated,-0.018004762143955078
CTNNB1 S37 mutants aren't phosphorylated,0.05381725737921253
CTNNB1 S45 mutants aren't phosphorylated,0.004855273272065722
CTNNB1 T41 mutants aren't phosphorylated,0.012354278983187762
APC truncation mutants have impaired AXIN binding,-0.043717736739970134
AXIN missense mutants destabilize the destruction complex,-0.020030366808998556
Truncations of AMER1 destabilize the destruction complex,-0.006893667307731393
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.009311087672754039
Maturation of hRSV A proteins,-0.004579606231521403
RHO GTPases activate KTN1,-0.00199933440513213
Deactivation of the beta-catenin transactivating complex,0.013453510986478782
Repression of WNT target genes,0.01554581949343061
FGFR4 ligand binding and activation,-0.012910732947374963
Phospholipase C-mediated cascade; FGFR4,0.02146464771881502
SHC-mediated cascade:FGFR4,0.06808322487492327
PI-3K cascade:FGFR4,0.05594271479686345
STAT3 nuclear events downstream of ALK signaling,0.0049495570592495925
Defective pyroptosis,-0.017577824004905263
ERK/MAPK targets,-0.019802549291090737
ERKs are inactivated,0.014686581832292883
TGFBR3 expression,-0.040296686978112055
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.03966705852241446
Class C/3 (Metabotropic glutamate/pheromone receptors),0.09271209882027692
FGFR1 mutant receptor activation,-0.024952787678896953
FGFR2 mutant receptor activation,0.03607435961875441
Activated point mutants of FGFR2,0.03196390406918404
Phospholipase C-mediated cascade; FGFR2,-0.009353299420006275
PI-3K cascade:FGFR1,-0.014960626392702056
PI-3K cascade:FGFR2,-0.025154081569760785
SHC-mediated cascade:FGFR2,0.008680968780596739
Signaling by FGFR2 IIIa TM,-0.012009410222707712
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.0011614505372505345
Abortive elongation of HIV-1 transcript in the absence of Tat,0.02820323154852284
FGFR2 alternative splicing,-0.00037813395386185247
Regulation of PTEN mRNA translation,0.032157833711788486
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.03024013823145279
NRIF signals cell death from the nucleus,-0.0009707397349912303
Signaling by KIT in disease,-0.01932754019016074
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.014028418422407781
Loss of function of MECP2 in Rett syndrome,0.0001931801613251162
Pervasive developmental disorders,-0.006414118299672381
Disorders of Developmental Biology,0.017690180614449793
Disorders of Nervous System Development,0.02692328904550963
Defects in vitamin and cofactor metabolism,-0.0029398902641564815
Regulation of FZD by ubiquitination,-0.010528440613332236
Serotonin receptors,-0.000775685676080012
p75NTR signals via NF-kB,0.02822848539611952
Signaling by NTRK3 (TRKC),-0.0011295652225054166
RAF activation,-0.005000723174160604
p75NTR regulates axonogenesis,-0.0024628767812401894
WNT ligand biogenesis and trafficking,-0.010840232818490253
